Literature DB >> 11006361

Application of a hybrid CFD-PBPK nasal dosimetry model in an inhalation risk assessment: an example with acrylic acid.

M Andersen1, R Sarangapani, R Gentry, H Clewell, T Covington, C B Frederick.   

Abstract

The available inhalation toxicity information for acrylic acid (AA) suggests that lesions to the nasal cavity, specifically olfactory degeneration, are the most sensitive end point for developing a reference concentration (RfC). Advances in physiologically based pharmacokinetic (PBPK) modeling, specifically the incorporation of computational fluid dynamic (CFD) models, now make it possible to estimate the flux of inhaled chemicals within the nasal cavity of experimental species, specifically rats. The focus of this investigation was to apply an existing CFD-PBPK hybrid model in the estimation of an RfC to determine the impact of incorporation of this new modeling technique into the risk assessment process. Information provided in the literature on the toxicity and mode of action for AA was used to determine the risk assessment approach. A comparison of the approach used for the current U.S. Environmental Protection Agency (U.S. EPA) RfC with the approach using the CFD-PBPK hybrid model was also conducted. The application of the CFD-PBPK hybrid model in a risk assessment for AA resulted in an RfC of 79 ppb, assuming a minute ventilation of 13.8 l/min (20 m(3)/day) in humans. This value differs substantially from the RfC of 0.37 ppb estimated for AA by the U.S. EPA before the PBPK modeling advances became available. The difference in these two RfCs arises from many factors, with the main difference being the species selected (mouse vs. rat). The choice to conduct the evaluation using the rat was based on the availability of dosimetry data in this species. Once these data are available in the mouse, an assessment should be conducted using this information. Additional differences included the methods used for estimating the target tissue concentration, the uncertainty factors (UFs) applied, and the application of duration and uncertainty adjustments to the internal target tissue dose rather than the external exposure concentration.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11006361     DOI: 10.1093/toxsci/57.2.312

Source DB:  PubMed          Journal:  Toxicol Sci        ISSN: 1096-0929            Impact factor:   4.849


  5 in total

1.  Magnetic resonance imaging and computational fluid dynamics (CFD) simulations of rabbit nasal airflows for the development of hybrid CFD/PBPK models.

Authors:  R A Corley; K R Minard; S Kabilan; D R Einstein; A P Kuprat; J R Harkema; J S Kimbell; M L Gargas; John H Kinzell
Journal:  Inhal Toxicol       Date:  2009-05       Impact factor: 2.724

2.  Comparative computational modeling of airflows and vapor dosimetry in the respiratory tracts of rat, monkey, and human.

Authors:  Richard A Corley; Senthil Kabilan; Andrew P Kuprat; James P Carson; Kevin R Minard; Richard E Jacob; Charles Timchalk; Robb Glenny; Sudhakar Pipavath; Timothy Cox; Christopher D Wallis; Richard F Larson; Michelle V Fanucchi; Edward M Postlethwait; Daniel R Einstein
Journal:  Toxicol Sci       Date:  2012-05-12       Impact factor: 4.849

3.  Computational Analysis of Deposition and Translocation of Inhaled Nicotine and Acrolein in the Human Body with E-cigarette Puffing Topographies.

Authors:  Ahmadreza Haghnegahdar; Yu Feng; Xiaole Chen; Jiang Lin
Journal:  Aerosol Sci Technol       Date:  2018-03-26       Impact factor: 2.908

Review 4.  Image-guided mathematical modeling for pharmacological evaluation of nanomaterials and monoclonal antibodies.

Authors:  Prashant Dogra; Joseph D Butner; Sara Nizzero; Javier Ruiz Ramírez; Achraf Noureddine; María J Peláez; Dalia Elganainy; Zhen Yang; Anh-Dung Le; Shreya Goel; Hon S Leong; Eugene J Koay; C Jeffrey Brinker; Vittorio Cristini; Zhihui Wang
Journal:  Wiley Interdiscip Rev Nanomed Nanobiotechnol       Date:  2020-04-21

5.  Accelerated Repurposing and Drug Development of Pulmonary Hypertension Therapies for COVID-19 Treatment Using an AI-Integrated Biosimulation Platform.

Authors:  Kaushik Chakravarty; Victor G Antontsev; Maksim Khotimchenko; Nilesh Gupta; Aditya Jagarapu; Yogesh Bundey; Hypatia Hou; Neha Maharao; Jyotika Varshney
Journal:  Molecules       Date:  2021-03-29       Impact factor: 4.411

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.